Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 USD | -1.17% | -9.82% | -88.56% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.67M | Capitalization | 17.4M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -41M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.51 x |
P/E ratio 2024 * |
-0.43
x | P/E ratio 2025 * |
-0.54
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | -1.17% | ||
1 week | -9.82% | ||
Current month | -85.00% | ||
1 month | -85.44% | ||
3 months | -90.69% | ||
6 months | -83.02% | ||
Current year | -88.56% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.27 | -1.17% | 980,533 |
24-05-23 | 0.2732 | -3.22% | 1,501,691 |
24-05-22 | 0.2823 | +2.51% | 960,080 |
24-05-21 | 0.2754 | -4.67% | 1,200,743 |
24-05-20 | 0.2889 | -3.51% | 1,676,141 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.56% | 17.4M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- GLYC Stock